The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis
VA Connecticut Healthcare System · Yale University · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,022
total citations
- FWCI
- 15.03
- Percentile
- 100%
- References
- 144
Citations per year
Authors
9- DCDeepak Cyril D’SouzaCorresponding
VA Connecticut Healthcare System
- EPEdward Perry
Yale University, VA Connecticut Healthcare System
- LMLisa Macdougall
Yale University, VA Connecticut Healthcare System
- YAYola Ammerman
Yale University, VA Connecticut Healthcare System
- TBThomas B. Cooper
Nathan Kline Institute for Psychiatric Research, Columbia University
Topics & keywords
Topics
Keywords
- Psychotomimetic
- Euphoriant
- Psychosis
- Psychology
- Cannabis
- Schizophrenia (object-oriented programming)
- Delta-9-tetrahydrocannabinol
- Cannabinoid
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.